Same industry

ATYR against four biotech peers, a year at 100

2550100200400800Feb ’26MayAugNov ’26AMGN+30.0%GILD+31.5%MRNA×8.4BIIB+41.0%ATYR×5.6

ATYR ×5.6. Moderna ×8.4, Biogen +41.0%, Gilead Sciences +31.5%, Amgen +30.0%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ATYR’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

ATYR: stories, the record and filings →